Taiwan FDA registration 37f7ca2f5c054e0d2e5060afecc0efa5

Bondis Free Light Chain Lambda Analysis Group (BN ProSpec)

TW: 邦迪斯自由輕鏈Lambda分析組(BN ProSpec)

Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Oct 26, 2009 – Oct 26, 2029Active

Registration details

Analysis ID: 37f7ca2f5c054e0d2e5060afecc0efa5
Customs Code: DHA00602039903

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This set of reagents is used in the Dade Behring BN ProSpec model to quantify lambda free light chains in serum and urine.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5550 Immunoglobulin (Specific Light Chain) Immunoassay System
Import Information: import

Dates and status

Registration Date: Oct 26, 2009
Expiry Date: Oct 26, 2029

About this record

Access comprehensive regulatory information for Bondis Free Light Chain Lambda Analysis Group (BN ProSpec) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 37f7ca2f5c054e0d2e5060afecc0efa5 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.